Investigators analyzed exfoliated cells in urine specimens to identify 50 candidate RNAs for prostate cancer detection.

The recent FDA approval of the IsoPSA blood test may represent a notable advancement in prostate cancer screening and diagnosis. Developed by Cleveland Diagnostics, the in vitro diagnostic instrument ...

MRI system significantly improves prostate cancer detection and efficiency. Find out how ProAI boosts accuracy and reduces ...

The FDA approved Cleveland Diagnostics' blood-based test to help diagnose high-grade prostate tumors and aid in biopsy decisions, the company announced.

Early detection of prostate cancer could soon be simplified, thanks to a University of Otago – Ōtākou Whakaihu Waka project.

June is Men's Health Awareness Month, and prostate cancer is one of the most common cancer diagnoses for men in the U.S. Dr. Jon LaPook joins to discuss symptoms, screenings and treatments. 25,591 ...

Fear of discomfort and unnecessary treatment often deters patients from prostate cancer screening, despite the benefits of early detection. Prostate cancer can be asymptomatic, making early detection ...

IsoPSA is a blood assay that detects variations of the PSA protein that signal a higher likelihood of high-grade tumors. It ...

—These findings suggest that conventional imaging significantly underestimates the extent of disease in high-risk, biochemically recurrent prostate cancer, potentially impacting treatment decisions ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. For American men, prostate cancer is the most common cancer ...

How to navigate a prostate cancer diagnosis – as screening decision announced - A major update on the possibility of a ...

The most common symptoms of prostate cancer are needing to urinate more often and straining to pee. Men may also feel as ...